Shp-2 Tyrosine Phosphatase Functions as a Negative Regulator of the Interferon-Stimulated Jak/STAT Pathway

Cited by (365)

Items 101–200 of 365

1. Tumor necrosis factor α attenuates interferon‐α signaling in the liver: involvement of SOCS3 and SHP2 and implication in resistance to interferon therapy
   Feng Hong, Van-Anh Nguyen, Bin Gao · 2001 · The FASEB Journal
2. Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis
   Wen-Qing Huang, Qing Lin, Xuan Zhuang, Liangliang Cai, Runsheng Ruan, Zhongxian Lu, Chi‐Meng Tzeng · 2014 · Current Cancer Drug Targets
3. Regulation of Signal Transducer and Activator of Transcription Signaling by the Tyrosine Phosphatase PTP-BL
   Masakiyo Nakahira, Takashi Tanaka, Bryanne E. Robson, Joseph P. Mizgerd, Michael J. Grusby · 2007 · Immunity
4. Lipoxin A4 inhibits TNF-α-induced production of interleukins and proliferation of rat mesangial cells
   Sheng‐Hua Wu, Chao Lu, Ling Dong, Guoping Zhou, Zha-Guang He, Ziqing Chen · 2005 · Kidney International
5. Anticancer Activity of Sodium Stibogluconate in Synergy with IFNs
   Taolin Yi, Manas K. Pathak, Daniel J. Lindner, Michael E. Ketterer, Carol F. Farver, Ernest C. Borden · 2002 · The Journal of Immunology
6. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway
   Xiangyang Yao, Fenfen Zhu, Zhihui Zhao, Chang Liu, Lan Luo, Zhimin Yin · 2011 · Journal of Cellular Biochemistry
7. Regulation of SOCS-1 Expression by Translational Repression
   Alexander Gregorieff, Stéphane Pyronnet, Nahum Sonenberg, André Veillette · 2000 · Journal of Biological Chemistry
8. Non-receptor protein tyrosine kinases.
   A. Tsygankov · 2003 · Frontiers in Bioscience
9. Activating and inhibitory signaling in mast cells: New opportunities for therapeutic intervention?
   Vanessa L. Ott, John C. Cambier · 2000 · Journal of Allergy and Clinical Immunology
10. Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment
    Mengyao Wu, Yilan Zhao, Chi Zhang, Kanyi Pu · 2024 · ACS Nano
11. Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses
    Mihyun Hwang, Cornelia C. Bergmann · 2018 · Journal of Virology
12. Turning off signal transducer and activator of transcription (STAT): The negative regulation of STAT signaling
    Weiguo Chen, Michael Daines, Gurjit K. Khurana Hershey · 2004 · Journal of Allergy and Clinical Immunology
13. Src Homology Domain 2-containing Tyrosine Phosphatase 2 Associates with Intercellular Adhesion Molecule 1 to Regulate Cell Survival
    Elżbieta Pluskota, Yi‐Ming Chen, Stanley E. D’Souza · 2000 · Journal of Biological Chemistry
14. Noonan Syndrome Mutation Q79R in Shp2 Increases Proliferation of Valve Primordia Mesenchymal Cells via Extracellular Signal–Regulated Kinase 1/2 Signaling
    Maike Krenz, Katherine E. Yutzey, Jeffrey M. Robbins · 2005 · Circulation Research
15. JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus
    Arturo Valle‐Mendiola, Adriana Gutiérrez‐Hoya, Isabel Soto‐Cruz · 2023 · Genes
16. A Kaposi's Sarcoma-Associated Herpesvirus Protein That Forms Inhibitory Complexes with Type I Interferon Receptor Subunits, Jak and STAT Proteins, and Blocks Interferon-Mediated Signal Transduction
    Sabine A. Bisson, Anne‐Laure Page, Don Ganem · 2009 · Journal of Virology
17. Repression of interferon-γ-induced inducible nitric oxide synthase (iNOS) gene expression in microglia by sodium butyrate is mediated through specific inhibition of ERK signaling pathways
    Jin‐Sun Park, Moon-Sook Woo, So Young Kim, Won-Ki Kim, Hee-Sun Kim · 2005 · Journal of Neuroimmunology
18. SHP2 forecast for the immune system: fog gradually clearing.
    Robert J. Salmond, D. Alexander · 2006 · Trends in immunology
19. Conditional Deletion of Shp2 in the Mammary Gland Leads to Impaired Lobulo-alveolar Outgrowth and Attenuated Stat5 Activation
    Yuehai Ke, Jacqueline Lesperance, Eric Erquan Zhang, Emilie Anne Bard-Chapeau, Robert G. Oshima, William J. Muller, Gen‐Sheng Feng · 2006 · Journal of Biological Chemistry
20. Inhibition of IFN-γ-Induced STAT1 Tyrosine Phosphorylation by Human CMV Is Mediated by SHP2
    Michel Baron, J. Davignon · 2008 · The Journal of Immunology
21. Signaling mechanisms of cytokine receptors and their perturbances in disease
    Ivo P. Touw, John P. de Koning, Alister C. Ward, Mirjam H. A. Hermans · 2000 · Molecular and Cellular Endocrinology
22. Enterovirus 71 Proteins 2A and 3D Antagonize the Antiviral Activity of Gamma Interferon via Signaling Attenuation
    Li-Chiu Wang, Su-O Chen, Shih-Ping Chang, Yi-Ping Lee, Chun‐Keung Yu, Chia‐Ling Chen, Po‐Chun Tseng, Chia-Yuan Hsieh, Shun‐Hua Chen, Chiou‐Feng Lin · 2015 · Journal of Virology
23. The Tiers and Dimensions of Evasion of the Type I Interferon Response by Human Cytomegalovirus
    Lisi Amsler, Marieke C. Verweij, Victor R. DeFilippis · 2013 · Journal of Molecular Biology
24. Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway
    L Wang, Tomohiro Kurosaki, Seth Joel Corey · 2006 · Oncogene
25. UFMylation inhibits the proinflammatory capacity of interferon-γ–activated macrophages
    Dale R. Balce, Yating Wang, Michael R. McAllaster, Bria F. Dunlap, Anthony Orvedahl, Barry L. Hykes, Lindsay Droit, Scott A. Handley, Craig B. Wilen, John G. Doench et al. · 2020 · Proceedings of the National Academy of Sciences
26. Selective Sequestration of STAT1 in the Cytoplasm via Phosphorylated SHP-2 Ameliorates Murine Experimental Colitis
    Xingxin Wu, Wenjie Guo, Limei Wu, Yanhong Gu, Liyun Gu, Su-Hai Xu, Xuefeng Wu, Yan Shen, Yuehai Ke, Ren Xiang Tan et al. · 2012 · The Journal of Immunology
27. Role of STAT3 in Transformation and Drug Resistance in CML
    Rajesh R. Nair, Joel Hassan G. Tolentino, Lori Hazlehurst · 2012 · Frontiers in Oncology
28. SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling
    Charlène Niogret, W. Birchmeier, G. Guarda · 2019 · Frontiers in Immunology
29. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase
    Sonia Godoy‐Tundidor, Ilaria Teresa Rita Cavarretta, Dietmar Fuchs, Matthias Fiechtl, Hannes Steiner, Katrin Friedbichler, Georg Hans Bartsch, Alfred Hobisch, Zoran Čulig · 2005 · The Prostate
30. Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-γ production in tumor microenvironment
    Peng Xiao, Yu Lian Guo, Haofei Zhang, X. Zhang, Hongqiang Cheng, Qian Cao, Yuehai Ke · 2018 · Oncogene
31. Phosphorylation of Grb2-Associated Binder 2 on Serine 623 by ERK MAPK Regulates Its Association with the Phosphatase SHP-2 and Decreases STAT5 Activation
    Mary Arnaud‐Arnould, Catherine Crouin, Catherine Déon, Denis Loyaux, Jacques H. Bertoglio · 2004 · The Journal of Immunology
32. Age-Associated Failure To Adjust Type I IFN Receptor Signaling Thresholds after T Cell Activation
    Guangjin Li, Jihang Ju, Cornelia M. Weyand, Jörg J. Goronzy · 2015 · The Journal of Immunology
33. Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): At the cross-road of pancreatic cancer cell proliferation
    Alessandra Dicitore, Michele Caraglia, Germano Gaudenzi, Gloria Irene Manfredi, Bruno Amato, Daniela Mari, Luca Persani, Claudio Arra, Giovanni Vitale · 2013 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
34. STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity
    Ashley Able, Jasmine A. Burrell, Jacqueline M. Stephens · 2017 · Biology
35. Dietary quercetin potentiates the antiproliferative effect of interferon-α in hepatocellular carcinoma cells through activation of JAK/STAT pathway signaling by inhibition of SHP2 phosphatase
    Ighodaro Igbe, Xiaofei Shen, Wei Jiao, Zhe Qiang, Teng Deng, Sheng Li, Wanli Liu, Han-Wei Liu, Guolin Zhang, Fei Wang · 2017 · Oncotarget
36. Inhibition of IFN-α signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway
    Zhimei Du, Yuhong Shen, Wentian Yang, Ingrid Mecklenbräuker, Benjamin G. Neel, Lionel B. Ivashkiv · 2005 · Proceedings of the National Academy of Sciences
37. Signal transduction by type I interferons.
    M. David · 2002 · BioTechniques
38. Jak2 Tyrosine Kinase: A True Jak of All Trades?
    Eric M. Sandberg, Tiffany A. Wallace, Michael D. Godeny, Danielle VonDerLinden, Peter P. Sayeski · 2004 · Cell Biochemistry and Biophysics
39. Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways
    Michele Caraglia, Maurizio Marra, Pierosandro Tagliaferri, Steven W. J. Lamberts, Silvia Zappavigna, Gabriella Misso, Francesco Cavagnini, Gaetano Facchini, A. Abbruzzese, Leo J. Hofland et al. · 2009 · Current Cancer Drug Targets
40. Methimazole As an Antioxidant and Immunomodulator in Thyroid Cells: Mechanisms Involving Interferon-γ Signaling and H2O2 Scavenging
    Ho Kim, Tae‐Hoon Lee, Young Sun Hwang, Mi Ae Bang, Kang Hwa Kim, Jae Mi Suh, Hyo Kyun Chung, Dae‐Yeul Yu, Kyung-Kwang Lee, O‐Yu Kwon et al. · 2001 · Molecular Pharmacology
41. Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs
    Latanya M. Scott, Liwei Chen, Kenyon G. Daniel, Wesley H. Brooks, Wayne C. Guida, Harshani R. Lawrence, Saı̈d M. Sebti, Nicholas J. Lawrence, Jie Wu · 2010 · Bioorganic & Medicinal Chemistry Letters
42. Modulation of the activation of Stat1 by the interferon-γ receptor complex
    Christopher D. Krause, Wen He, Sergei V. Kotenko, Sidney Pestka · 2006 · Cell Research
43. Osteopontin Induces Ubiquitin-Dependent Degradation of STAT1 in RAW264.7 Murine Macrophages
    Chengjiang Gao, Hongtao Guo, Zhiyong Mi, Michael J. Grusby, Paul C. Kuo · 2007 · The Journal of Immunology
44. Role of the cytoplasmic domains of the type I interferon receptor subunits in signaling
    Christine Prejean, Oscar R. Colamonici · 2000 · Seminars in Cancer Biology
45. Vanadate Facilitates Interferon α-mediated Apoptosis That Is Dependent on the Jak/Stat Pathway
    Ana M. Gamero, Andrew C. Larner · 2001 · Journal of Biological Chemistry
46. Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis
    Devki Nandan, Keith L. Knutson, Raymond Lo, Neil E. Reiner · 2000 · Journal of Leukocyte Biology
47. Usnic acid suppresses cervical cancer cell proliferation by inhibiting PD‐L1 expression and enhancing T‐lymphocyte tumor‐killing activity
    Tong Sun, Ming Yue Li, Zhi Hong Zhang, Jing Ying Wang, Yue Xing, MyongHak Ri, Cheng Hua Jin, Guang Hua Xu, Lian Xun Piao, Hong Lan Jin et al. · 2021 · Phytotherapy Research
48. Deficient SOCS3 and SHP-1 Expression in Psoriatic T Cells
    Karsten Wessel Eriksen, Anders Woetmann, Lone Skov, Thorbjørn Krejsgaard, Lone Frier Bovin, Mikkel L. Hansen, Kirsten Grønbæk, Nils Billestrup, Mogens Holst Nissen, Carsten Geisler et al. · 2010 · Journal of Investigative Dermatology
49. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells
    Zhengfu Tai, Yuan Lin, Yujiao He, Junmei Huang, Jiajia Guo, Lijuan Yang, Guolin Zhang, Fei Wang · 2013 · Cellular Signalling
50. Diverse mechanisms evolved by DNA viruses to inhibit early host defenses
    Marni S. Crow, Krystal K. Lum, Xinlei Sheng, Bokai Song, Ileana M. Cristea · 2016 · Critical Reviews in Biochemistry and Molecular Biology
51. Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112
    Liwei Chen, Daniele Pernazza, Latanya M. Scott, Harshani R. Lawrence, Yuan Ren, Yunting Luo, Xin Wu, Shen‐Shu Sung, Wayne C. Guida, Saı̈d M. Sebti et al. · 2010 · Biochemical Pharmacology
52. Regulation of p27Kip1 phosphorylation and G1 cell cycle progression by protein phosphatase PPM1G.
    Chuang Sun, Gaohang Wang, Katharine H. Wrighton, Han Lin, Zhou Songyang, Xin‐Hua Feng, Xia Lin · 2016 · PubMed Central
53. Epithelial Tyrosine Phosphatase SHP-2 Protects against Intestinal Inflammation in Mice
    Geneviève Coulombe, Caroline Leblanc, Sébastien Cagnol, Faïza Maloum-Rami, Étienne Lemieux, Nathalie Perreault, Gen‐Sheng Feng, François Boudreau, Nathalie Rivard · 2013 · Molecular and Cellular Biology
54. Transcription Protein STAT1: Biology and Relation to Cancer
    Ljubina Adámková, Kamila Součková, Jan Kovařík · 2007 · Folia Biologica
55. Helicobacter pylori Infection Activates Src Homology-2 Domain–Containing Phosphatase 2 To Suppress IFN-γ Signaling
    Yu‐Chih Wang, Chia‐Ling Chen, Bor‐Shyang Sheu, Yao‐Jong Yang, Po‐Chun Tseng, Chia-Yuan Hsieh, Chiou‐Feng Lin · 2014 · The Journal of Immunology
56. Genetic background influences Th cell differentiation by controlling the capacity for IL-2-induced IL-4 production by naive CD4+ T cells
    Junji Yagi, Yutaka Arimura, Hiroaki Takatori, Hideaki Nakajima, Itsuo Iwamoto, Takashi Uchiyama · 2006 · International Immunology
57. Protein Tyrosine Phosphatase SHP-2 (PTPN11) in Hematopoiesis and Leukemogenesis
    Xia Liu, Cheng‐Kui Qu · 2011 · Journal of Signal Transduction
58. Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds
    Wenjie Guo, Qiang Xu · 2020 · Journal of Pharmacological Sciences
59. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis
    Chun‐Jung Chang, Chiou‐Feng Lin, Chih‐Hsin Lee, Hsiao‐Chi Chuang, Fu-Chia Shih, Shu-Wen Wan, Chi Tai, Chia‐Ling Chen · 2020 · Biochemical Pharmacology
60. Epithelial-to-mesenchymal transition hinders interferon-γ-dependent immunosurveillance in lung cancer cells
    Po‐Chun Tseng, Chia‐Ling Chen, Kang-Yuan Lee, Po‐Hao Feng, Yu‐Chih Wang, Rahmat Dani Satria, Chiou‐Feng Lin · 2022 · Cancer Letters
61. Interferon-γ in foam cell formation and progression of atherosclerosis
    Xiaohua Yu, Jian Zhang, Xi‐Long Zheng, Yun-Hua Yang, Chao‐Ke Tang · 2014 · Clinica Chimica Acta
62. Regulation of SHP2 by PTEN/AKT/GSK-3β signaling facilitates IFN-γ resistance in hyperproliferating gastric cancer
    Po‐Chun Tseng, Wei‐Ching Huang, Chia‐Ling Chen, Bor‐Shyang Sheu, Yan‐Shen Shan, Cheng‐Chieh Tsai, Chi‐Yun Wang, Su-O Chen, Chia-Yuan Hsieh, Chiou‐Feng Lin · 2012 · Immunobiology
63. Expression and Clinical Significance of SHP2 in Gastric Cancer
    Shengzhang Dong, Li Fq, Q Zhang, K-Z Lv, H-L Yang, Yuzhen Gao, J-R Yu · 2012 · Journal of International Medical Research
64. Role of SHP-2 Tyrosine Phosphatase in the DNA Damage-induced Cell Death Response
    Liangping Yuan, Wen‐Mei Yu, Zhi-Min Yuan, Christian C. Haudenschild, Cheng‐Kui Qu · 2003 · Journal of Biological Chemistry
65. Inhibition of Tumor Necrosis Factor-α–Induced SHP-2 Phosphatase Activity by Shear Stress
    Nicole Lerner‐Marmarosh, Masanori Yoshizumi, Wenyi Che, James Surapisitchat, Hisaaki Kawakatsu, Masashi Akaike, Bo Ding, Qunhua Huang, Yan Chen, Bradford C. Berk et al. · 2003 · Arteriosclerosis Thrombosis and Vascular Biology
66. Shp2 as a therapeutic target for leptin resistance and obesity
    Gen‐Sheng Feng · 2006 · Expert Opinion on Therapeutic Targets
67. Complex systems biology approach to understanding coordination of JAK-STAT signaling
    Radina P. Soebiyanto, Sree N. Sreenath, Cheng‐Kui Qu, Kenneth A. Loparo, Kevin D. Bunting · 2007 · Biosystems
68. Role of Aspergillus fumigatus in Triggering Protease-Activated Receptor-2 in Airway Epithelial Cells and Skewing the Cells toward a T-helper 2 Bias
    Tetsuya Homma, Atsushi Kato, Bharat Bhushan, James E. Norton, Lydia A. Suh, Roderick G. Carter, Dave S. Gupta, Robert P. Schleimer · 2015 · American Journal of Respiratory Cell and Molecular Biology
69. Inhibition of host cell signal transduction by Leishmania: observations relevant to the selective impairment of IL-12 responses
    Mary Ann McDowell, David L. Sacks · 1999 · Current Opinion in Microbiology
70. Dephosphorylation Failure of Tyrosine-Phosphorylated STAT1 in IFN-Stimulated Sendai Virus C Protein-Expressing Cells
    Sakura Saito, T. Ogino, Naoko Miyajima, Atsushi Kato, Masayoshi Kohase · 2002 · Virology
71. Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation
    Kathy S. Wang, Emmanuel Zorn, Jerome Ritz · 2001 · Blood
72. Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3
    Chen Qi, T. Han, Hua Tang, Ke-Nan Huang, Jie Min, Jing Li, Xin-Yu Ding, Zhi-fei Xu · 2017 · International Journal of Molecular Sciences
73. Specific Inhibition of Stat5a/b Promotes Apoptosis of IL-2-Responsive Primary and Tumor-Derived Lymphoid Cells
    Fariba Behbod, Zsuzsanna S. Nagy, Stanislaw M. Stepkowski, James G. Karras, Charlene R. Johnson, W. David Jarvis, Robert Arthur Kirken · 2003 · The Journal of Immunology
74. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    A.R.M. Ruhul Amin, Myat Lin Oo, Takeshi Senga, Noriko Suzuki, Gen‐Sheng Feng, Michinari Hamaguchi · 2003 · PubMed
75. Flow signaling and atherosclerosis
    Nhat‐Tu Le, Uday Gajjandra Sandhu, Raymundo A. Quintana-Quezada, Nguyet Minh Hoang, Keigi Fujiwara, Jun‐ichi Abe · 2016 · Cellular and Molecular Life Sciences
76. Inhibition of Response to Alpha Interferon byMycobacterium tuberculosis
    Savita Prabhakar, Yaming Qiao, Yoshihiko Hoshino, Michael D. Weiden, Antony Canova, Elena Giacomini, Eliana Marina Coccia, Richard I. Pine · 2003 · Infection and Immunity
77. Raft-mediated Src Homology 2 Domain-containing Proteintyrosine Phosphatase 2 (SHP-2) Regulation in Microglia
    Hee Young Kim, Soo Jung Park, Eun-hye Joe, Ilo Jou · 2006 · Journal of Biological Chemistry
78. Recruitment of the Protein-tyrosine Phosphatase SHP-2 to the C-terminal Tyrosine of the Prolactin Receptor and to the Adaptor Protein Gab2
    Samir Ali, Suhad Ali · 2000 · Journal of Biological Chemistry
79. Cross-talk between interleukin 1β (IL-1β) and IL-6 signalling pathways: IL-1β selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism
    Xue‐Ning Shen, Zhigang Tian, Michael J. Holtzman, Bin Gao · 2000 · Biochemical Journal
80. The Signal Transduction of the Growth Hormone Receptor Is Regulated by the Ubiquitin/Proteasome System and Continues After Endocytosis
    Cristina M. Alves dos Santos, Peter van Kerkhof, Ger J. Strous · 2001 · Journal of Biological Chemistry
81. Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond
    Niki Karachaliou, Rafael Rosell, Daniela Morales-Espinosa, Santiago Viteri · 2014 · Expert Review of Anticancer Therapy
82. T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice
    Wen Liu, Wenjie Guo, Lihong Shen, Zhen Chen, Qiong Luo, Xiaolin Luo, Gen‐Sheng Feng, Yongqian Shu, Yanhong Gu, Qiang Xu et al. · 2016 · Oncotarget
83. SHP-2 Binds to Caveolin-1 and Regulates Src Activity via Competitive Inhibition of CSK in Response to H2O2 in Astrocytes
    Ara Jo, Hyun‐Ju Park, Sung-Hee Lee, So-Hee Ahn, Hee Ja Kim, Eun‐Mi Park, Youn‐Hee Choi · 2014 · PLoS ONE
84. Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2) expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro
    Hongjun Xie, Shengyun Huang, Wengang Li, Hongbo Zhao, Tianqi Zhang, Dongsheng Zhang · 2013 · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
85. Mathematical modelling of interferon-γ signalling in pancreatic stellate cells reflects and predicts the dynamics of STAT1 pathway activity
    Katja Rateitschak, Anna Karger, Brit Fitzner, Falko Lange, Olaf Wolkenhauer A, Robert Jaster · 2009 · Cellular Signalling
86. Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects
    Taolin Yi, Paul J. Elson, Masato Mitsuhashi, Barbara Jacobs, Emese Hollovary, G. Thomas Budd, Timothy Peter Spiro, Pierre L. Triozzi, Ernest C. Borden · 2011 · Oncotarget
87. SH2 Domain-Containing Protein-Tyrosine Phosphatases
    Benjamin G. Neel, Gordon Chan, Salim Dhanji · 2010 · Elsevier eBooks
88. Intra-articular basic calcium phosphate and monosodium urate crystals inhibit anti-osteoclastogenic cytokine signalling
    Clare C. Cunningham, Emma M. Corr, Géraldine McCarthy, Aisling Dunne · 2016 · Osteoarthritis and Cartilage
89. Transcriptional regulation in neutrophils: teaching old cells new tricks.
    P. P. McDonald · 2004 · Advances in Immunology
90. Dendritic Cell-Based Tumor Vaccines and Antigen Presentation Attenuators
    Kevin Evel-Kabler, Si‐Yi Chen · 2006 · Molecular Therapy
91. The Janus Kinase Inhibitor, JAB/SOCS-1, Is an Interferon-γ Inducible Gene and Determines the Sensitivity to Interferons
    Hiroshi Sakamoto, Ichiko Kinjyo, Akihiko Yoshimura · 2000 · Leukemia & lymphoma/Leukemia and lymphoma
92. NRAMP-1 Expression Modulates Protein-tyrosine Phosphatase Activity in Macrophages
    María Adelaida Gómez, Samantha Li, Michel L. Tremblay, Martin Olivier · 2007 · Journal of Biological Chemistry
93. E3 ubiquitin ligase NKLAM ubiquitinates STAT1 and positively regulates STAT1-mediated transcriptional activity
    Donald W. Lawrence, Jacki Kornbluth · 2016 · Cellular Signalling
94. Thyrotropin-Mediated Repression of Class II Trans -Activator Expression in Thyroid Cells: Involvement of STAT3 and Suppressor of Cytokine Signaling
    Hohyun Kim, Jae Mi Suh, Eun Suk Hwang, Dong Wook Kim, Hyo Kyun Chung, Jung Hun Song, Jung Hwan Hwang, Ki Cheol Park, Heung Kyu Ro, Eun‐Kyeong Jo et al. · 2003 · The Journal of Immunology
95. Cells Previously Desensitized to Type 1 Interferons Display Different Mechanisms of Activation of Stat-dependent Gene Expression from Naïve Cells
    Sakamoto, Shuji, Qin, Jinzhong, Navarro, Angels, Gamero, Ana, Potla, Ramesh, Yi, Taolin, Zhu, Wei, Baker, Darren P., Feldman, Gerald, Larner, Andrew C. · 2004 · Journal of Biological Chemistry
96. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C
    Svetlana Radaeva, Barbara Jaruga, Won–Ho Kim, Theo Heller, T. Jake Liang, Bin Gao · 2004 · Biochemical Journal
97. The Shp-2 tyrosine phosphatase
    Lisa Ann Lai, Chunmei Zhao, Eric Erquan Zhang, Gen‐Sheng Feng · 2003 · Topics in current genetics
98. Interleukin-12 treatment down-regulates STAT4 and induces apoptosis with increasing ROS production in human natural killer cells
    Yong Huang, Yingfeng Lei, Hai Zhang, Mingjie Zhang, Andrew I. Dayton · 2011 · Journal of Leukocyte Biology
99. New and Unexpected Biological Functions for the Src-Homology 2 Domain-Containing Phosphatase SHP-2 in the Gastrointestinal Tract
    Geneviève Coulombe, Nathalie Rivard · 2015 · Cellular and Molecular Gastroenterology and Hepatology
100. The tyrosine phosphatase SHP2 promotes proliferation and oxaliplatin resistance of colon cancer cells through AKT and ERK
     Mengchao Yu, Chengzhen Xu, Hongwei Zhang, Jie Lun, Lei Wang, Gang Zhang, Jing Susan Fang · 2021 · Biochemical and Biophysical Research Communications